Drugs Made In America Acquisition II Corp. (DMII)
Nasdaq: DMII · Blank Checks · filing with the SEC since 2025
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars. The fiscal year ends in December.| Fiscal year | FY 2025 |
|---|---|
| Period ending | Dec 31, 2025 |
| Report filed | Apr 15, 2026 |
| General and administrative | 488,385 |
| Total operating expenses | 488,385 |
| Total costs and expenses | 77,799 |
| Operating income | -488,385 |
| Interest and investment income | 4,933,800 |
| Total non-operating income (expense) | 4,675,435 |
| Net income | 4,187,050 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
General and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:OperatingCostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLoss